142 related articles for article (PubMed ID: 38135144)
1. Endocrine tumors of the female reproductive tract.
Asa SL; Ezzat S
Mol Cell Endocrinol; 2024 Mar; 582():112123. PubMed ID: 38135144
[TBL] [Abstract][Full Text] [Related]
2. Ovarian sex cord-stromal tumors in patients with probable or confirmed germline DICER1 mutations.
Oost EE; Charles A; Choong CS; Leung YC; Salfinger S; Sonnendecker H; Tan J; Townshend S; Witkowski L; Foulkes WD; Stewart CJ
Int J Gynecol Pathol; 2015 May; 34(3):266-74. PubMed ID: 25844550
[TBL] [Abstract][Full Text] [Related]
3. On the Chopping Block: Overview of DICER1 Mutations in Endocrine and Neuroendocrine Neoplasms.
Juhlin CC
Surg Pathol Clin; 2023 Mar; 16(1):107-118. PubMed ID: 36739158
[TBL] [Abstract][Full Text] [Related]
4. From Malignant Thyroid Teratoma to Thyroblastoma: Evolution of a Newly-recognized DICER1 -associated Malignancy.
Rooper LM
Adv Anat Pathol; 2023 Mar; 30(2):136-145. PubMed ID: 36069850
[TBL] [Abstract][Full Text] [Related]
5. DICER1 and FOXL2 Mutation Status Correlates With Clinicopathologic Features in Ovarian Sertoli-Leydig Cell Tumors.
Karnezis AN; Wang Y; Keul J; Tessier-Cloutier B; Magrill J; Kommoss S; Senz J; Yang W; Proctor L; Schmidt D; Clement PB; Gilks CB; Huntsman DG; Kommoss F
Am J Surg Pathol; 2019 May; 43(5):628-638. PubMed ID: 30986800
[TBL] [Abstract][Full Text] [Related]
6. A survey of DICER1 hotspot mutations in ovarian and testicular sex cord-stromal tumors.
Conlon N; Schultheis AM; Piscuoglio S; Silva A; Guerra E; Tornos C; Reuter VE; Soslow RA; Young RH; Oliva E; Weigelt B
Mod Pathol; 2015 Dec; 28(12):1603-12. PubMed ID: 26428316
[TBL] [Abstract][Full Text] [Related]
7. Ovarian sex cord-stromal tumors, pleuropulmonary blastoma and DICER1 mutations: a report from the International Pleuropulmonary Blastoma Registry.
Schultz KA; Pacheco MC; Yang J; Williams GM; Messinger Y; Hill DA; Dehner LP; Priest JR
Gynecol Oncol; 2011 Aug; 122(2):246-50. PubMed ID: 21501861
[TBL] [Abstract][Full Text] [Related]
8. DICER1-associated Tumors in the Female Genital Tract: Molecular Basis, Clinicopathologic Features, and Differential Diagnosis.
Han LM; Weiel JJ; Longacre TA; Folkins AK
Adv Anat Pathol; 2022 Sep; 29(5):297-308. PubMed ID: 35778792
[TBL] [Abstract][Full Text] [Related]
9. Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers.
Heravi-Moussavi A; Anglesio MS; Cheng SW; Senz J; Yang W; Prentice L; Fejes AP; Chow C; Tone A; Kalloger SE; Hamel N; Roth A; Ha G; Wan AN; Maines-Bandiera S; Salamanca C; Pasini B; Clarke BA; Lee AF; Lee CH; Zhao C; Young RH; Aparicio SA; Sorensen PH; Woo MM; Boyd N; Jones SJ; Hirst M; Marra MA; Gilks B; Shah SP; Foulkes WD; Morin GB; Huntsman DG
N Engl J Med; 2012 Jan; 366(3):234-42. PubMed ID: 22187960
[TBL] [Abstract][Full Text] [Related]
10. Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT) Commonly Exhibits Positivity With Sex Cord Markers FOXL2 and SF-1 but Lacks FOXL2 and DICER1 Mutations.
Croce S; de Kock L; Boshari T; Hostein I; Velasco V; Foulkes WD; McCluggage WG
Int J Gynecol Pathol; 2016 Jul; 35(4):301-8. PubMed ID: 26598979
[TBL] [Abstract][Full Text] [Related]
11. Gynecologic and reproductive health in patients with pathogenic germline variants in DICER1.
Merideth MA; Harney LA; Vyas N; Bachi A; Carr AG; Hill DA; Dehner LP; Schultz KAP; Stewart DR; Stratton P
Gynecol Oncol; 2020 Mar; 156(3):647-653. PubMed ID: 31952842
[TBL] [Abstract][Full Text] [Related]
12. Recurrent DICER1 Hotspot Mutations in Malignant Thyroid Gland Teratomas: Molecular Characterization and Proposal for a Separate Classification.
Rooper LM; Bynum JP; Miller KP; Lin MT; Gagan J; Thompson LDR; Bishop JA
Am J Surg Pathol; 2020 Jun; 44(6):826-833. PubMed ID: 31917706
[TBL] [Abstract][Full Text] [Related]
13. DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: Clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor Registry.
Schultz KAP; Harris AK; Finch M; Dehner LP; Brown JB; Gershenson DM; Young RH; Field A; Yu W; Turner J; Cost NG; Schneider DT; Stewart DR; Frazier AL; Messinger Y; Hill DA
Gynecol Oncol; 2017 Dec; 147(3):521-527. PubMed ID: 29037807
[TBL] [Abstract][Full Text] [Related]
14. Gynecologic Manifestations of the DICER1 Syndrome.
Stewart CJ; Charles A; Foulkes WD
Surg Pathol Clin; 2016 Jun; 9(2):227-41. PubMed ID: 27241106
[TBL] [Abstract][Full Text] [Related]
15. Clinical Characteristics and Mutation Analyses of Ovarian Sertoli-Leydig Cell Tumors.
Yuan Z; Huo X; Jiang D; Yu M; Cao D; Wu H; Shen K; Yang J; Zhang Y; Zhou H; Wang Y
Oncologist; 2020 Sep; 25(9):e1396-e1405. PubMed ID: 32557933
[TBL] [Abstract][Full Text] [Related]
16. Germline and somatic DICER1 mutations in familial and sporadic liver tumors.
Caruso S; Calderaro J; Letouzé E; Nault JC; Couchy G; Boulai A; Luciani A; Zafrani ES; Bioulac-Sage P; Seror O; Imbeaud S; Zucman-Rossi J
J Hepatol; 2017 Apr; 66(4):734-742. PubMed ID: 28012864
[TBL] [Abstract][Full Text] [Related]
17. Malignant teratoid tumor of the thyroid gland: an aggressive primitive multiphenotypic malignancy showing organotypical elements and frequent DICER1 alterations-is the term "thyroblastoma" more appropriate?
Agaimy A; Witkowski L; Stoehr R; Cuenca JCC; González-Muller CA; Brütting A; Bährle M; Mantsopoulos K; Amin RMS; Hartmann A; Metzler M; Amr SS; Foulkes WD; Sobrinho-Simões M; Eloy C
Virchows Arch; 2020 Dec; 477(6):787-798. PubMed ID: 32507920
[TBL] [Abstract][Full Text] [Related]
18. Presacral malignant teratoid neoplasm in association with pathogenic DICER1 variation.
Nakano Y; Hasegawa D; Stewart DR; Schultz KAP; Harris AK; Hirato J; Uemura S; Tamura A; Saito A; Kawamura A; Yoshida M; Yamasaki K; Yamashita S; Ushijima T; Kosaka Y; Ichimura K; Dehner LP; Hill DA
Mod Pathol; 2019 Dec; 32(12):1744-1750. PubMed ID: 31296931
[TBL] [Abstract][Full Text] [Related]
19. Ovarian Sertoli-Leydig Cell Tumor with Elevated Inhibin B as a Cause of Secondary Amenorrhea in an Adolescent with Germ Line DICER1 Mutation.
Luke AM; Moroney JW; Snitchler A; Whiteway SL
J Pediatr Adolesc Gynecol; 2017 Oct; 30(5):598-600. PubMed ID: 28502826
[TBL] [Abstract][Full Text] [Related]
20. A Genome-First Approach to Characterize DICER1 Pathogenic Variant Prevalence, Penetrance, and Phenotype.
Mirshahi UL; Kim J; Best AF; Chen ZE; Hu Y; Haley JS; Golden A; Stahl R; Manickam K; Carr AG; Harney LA; Field A; Hatton J; Schultz KAP; Bauer AJ; Hill DA; Rosenberg PS; Murray MF; Carey DJ; Stewart DR
JAMA Netw Open; 2021 Feb; 4(2):e210112. PubMed ID: 33630087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
